Tag Archives: policy

Rare Diseases Lead to Unique Legislation

By Jennifer Ringler | Published: February 29, 2012
Since 1983, pharma and patent organizations have been working together to influence policy aimed at improving the lives of those with rare diseases. In 1983—with the help of Abbey Meyers and the drive she had to help her son (more on that here)—the Orphan Drug Act was passed to incentivize pharma to step up and play [...]
Posted in Events, Global, Legal | Also tagged , , , , , | Leave a comment

Does Pharma Have a Debt Crisis Strategy?

By William Looney and Ben Comer | Published: July 20, 2011
The Obama Administration’s proposed fiscal budget for 2012 suggested that all bets are off for biopharmaceutical revenue safeguards, but it never had a chance with Congress, as evidenced by a unanimous no-thank-you from the Senate in late May. But that was before debt ceiling talks and the alleged possibility of a default emerged as the [...]
Posted in Corporate Responsibility, Europe, Global, Strategy, healthcare, leadership, pricing | Also tagged , , , , | 1 Comment

EU Pharma Policy 2010: Resolutions? Yes. Solutions? Maybe.

By Julian Upton | Published: January 4, 2010
Guest blog post by Reflector, Pharm Exec Europe’s Brussels correspondent. There was a new air of hope and confidence among officials and diplomats at the turn of the year in Brussels — or at least there would have been if anyone had been at work. 2010 promises a new beginning with the entry into force of [...]
Posted in Europe, Global, Regulatory | Also tagged , , , , | Leave a comment